Tigecycline 12-oxo-11-hydroxy is a glycylcycline derivative featuring a tetracyclic core substituted with a 11ฮฒ-hydroxy group and a 12-oxo functionality, reflecting oxidative modifications at positions 11 and 12 relative to the parent tigecycline structure. The hydroxylation at C-11 introduces a chiral center, while the ketone at C-12 disrupts the native lactam bridge, altering pharmacophoric properties. This impurity arises via oxidative degradation pathways during synthesis or storage, necessitating its quantification as a critical quality attribute. It serves as an HPLC reference standard for impurity profiling in tigecycline drug substance analysis.
